Amplitude Venture Capital

Amplitude Venture Capital is a prominent Canadian venture capital firm based in Montréal, dedicated to building and investing in the next generation of life science companies. Established with a clear focus on transforming scientific innovation into commercial success, Amplitude targets opportunities from inception through to commercialization. The firm leverages a deep understanding of the life sciences sector, aiming to address significant unmet medical needs through novel platforms and therapies. Their investment thesis emphasizes the creation of robust, globally competitive companies within Canada's burgeoning biotech ecosystem.

The firm's investment strategy is characterized by its hands-on approach and commitment to leading significant funding rounds. Amplitude typically leads Series A and Series B rounds, providing substantial capital to fuel the development and growth of its portfolio companies. Initial investments from Amplitude Venture Capital generally range from C$5 million to C$15 million, which translates to approximately $3.65 million to $10.95 million USD based on current exchange rates. This considerable check size allows them to support ambitious projects that require significant capital for research, development, and clinical trials.

Amplitude has demonstrated strong fundraising capabilities, having successfully closed two major funds. Their first fund, launched in 2020, secured C$200 million, while their second fund, announced in 2023, raised an impressive C$300 million. Collectively, these funds provide Amplitude with over C$500 million in committed capital, solidifying its position as a major player in the Canadian life sciences venture landscape. Beyond capital, Amplitude offers strategic guidance, operational support, and access to an extensive network of industry experts, aiming to accelerate the journey of its portfolio companies from scientific discovery to market leadership.